This protocol is judged by an institutional overview board, an unbiased team that opinions any clinical trials involving humans. If a study includes a Program I drug, after the board approves the protocol as moral, the researchers need to make an application for an investigational new drug (IND) selection in the FDA.Though the protocols required t